Felix A M, Heimer E P, Wang C T, Lambros T J, Swistok J, Roszkowski M, Ahmad M, Confalone D, Scott J W, Parker D
Int J Pept Protein Res. 1985 Aug;26(2):130-48. doi: 10.1111/j.1399-3011.1985.tb03190.x.
A novel synthesis of thymosin alpha 1 by classical methods using seven tert.-butyl side chain protected fragments is described. Optimum conditions were found for the final DCC/HOBt coupling of the two key intermediates; decapeptide and octadecapeptide. Thymosin alpha 1 was purified by two stages of preparative HPLC (partial purification with C8 and final purification with C18 reverse phase silica gel) to give a 30% overall yield for the final four stages of synthesis (including catalytic hydrogenation of octadecapeptide, coupling, deprotection and purification). The product was shown to be homogeneous by thin-layer and paper high voltage electrophoresis, isoelectric focusing analysis, thin-layer chromatography and high performance liquid chromatography. Amino acid analysis, optical rotation, 1H-n.m.r. spectroscopy, FAB mass spectroscopy and peptide mapping after tryptic digestion confirmed the structure of thymosin alpha 1. Three minor stereoisomer contaminants were isolated by HPLC and characterized as [D-Lys14]-thymosin alpha 1, [D-Lys17]-thymosin alpha 1 and [D-Ala3]-thymosin alpha 1 resulting from racemization at Lys14, Lys17 and Ala3 during the coupling of the fragments. A final contaminant, isolated by HPLC, was characterized as N alpha-isobutyloxycarbonyl-thymosin alpha 1 (15-28), which results from "wrong way opening" of an activated mixed anhydride.
描述了一种通过经典方法使用七个叔丁基侧链保护片段合成胸腺素α1的新方法。找到了两种关键中间体(十肽和十八肽)最终DCC/HOBt偶联的最佳条件。胸腺素α1通过制备型HPLC的两个阶段进行纯化(先用C8进行部分纯化,最后用C18反相硅胶进行纯化),以在合成的最后四个阶段(包括十八肽的催化氢化、偶联、脱保护和纯化)获得30%的总收率。通过薄层和纸高压电泳、等电聚焦分析、薄层色谱和高效液相色谱表明产物是均一的。氨基酸分析、旋光度、1H-核磁共振光谱、快原子轰击质谱和胰蛋白酶消化后的肽图分析证实了胸腺素α1的结构。通过HPLC分离出三种次要的立体异构体污染物,并鉴定为[D-Lys14]-胸腺素α1、[D-Lys17]-胸腺素α1和[D-Ala3]-胸腺素α1,它们是在片段偶联过程中Lys14、Lys17和Ala3处发生消旋化产生的。通过HPLC分离出的最后一种污染物被鉴定为Nα-异丁氧基羰基-胸腺素α1(15-28),它是由活化的混合酸酐的“错误开环”产生的。